Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenetic Susceptibility to Inflammatory Complications After Cardiac Surgery (Epi-SICCS)

NCT07865026 is registered in ClinicalTrials.gov with University of Glasgow as lead sponsor.

NCT NCT07865026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07865026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenetic Susceptibility to Inflammatory Complications After Cardiac Surgery (Epi-SICCS)
Lead sponsor
University of Glasgow
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
March 31, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass graft, epigenetic, inflammation, inflammation in cardiac surgery, organ dysfunction, postoperative complications